Page last updated: 2024-12-07

dehydroevodiamine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

dehydroevodiamine: RN given refers to hydroxide, inner salt; structure in first source. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID9817839
MeSH IDM0091939

Synonyms (19)

Synonym
dehydroevodiamine
67909-49-3
AKOS016010126
FT-0689188
14-methyl-5-oxo-7,8-dihydro-5h-indolo[2',3':3,4]pyrido[2,1-b]quinazolin-14-ium-13-ide
Q-100762
14-methyl-5-oxo-7,8-dihydro-5h-indolo[2',3':3,4]-pyrido[2,1-b]quinazolin-14-ium-13-ide
HY-N2106
BS-17904
HMS3885I06
CCG-267480
O10369
CS-0018627
A867162
AC-34607
GLXC-14697
evodiamine, dehydro-
8NT3HW64V9
indolo[2',3':3,4]pyrido[2,1-b]quinazolinium, 5,7,8,13-tetrahydro-14-methyl-5-oxo-, inner salt

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" The pharmacokinetic parameters were quite different between single herbs and Zuojinwan prescription."( Comparative pharmacokinetics of dehydroevodiamine and coptisine in rat plasma after oral administration of single herbs and Zuojinwan prescription.
Di, X; Liu, Y; Shen, W; Wang, Y; Yan, R, 2011
)
0.37
"A simple and sensitive high-performance liquid chromatographic method was developed for the simultaneous determination and pharmacokinetic analysis of seven alkaloids dehydroevodiamine (DHED), 10-hydroxyrutaecarpine (HDR), evodiamine (EDM), rutaecarpine (RCP), 1-methyl-2-n-nonyl-4(1H)quinolone (MNQ), evocarpine (ECP), and dihydroevocarpine (DHE), and two flavonoids isorhamnetin-7-O-rutinoside (RIM) and diosmetin-7-O-β-d-glucopyranoside (GRD) in rat plasma after oral administration of Wuzhuyu decoction."( Simultaneous determination and pharmacokinetic analysis of seven alkaloids and two flavonoids from rat plasma by HPLC-DAD after oral administration of Wuzhuyu decoction.
Hu, CQ; Li, F; Yang, XW, 2012
)
0.38
" This approach was found to be capable of providing complete pharmacokinetic parameters as well as the typical pharmacokinetic assay calibrated by authentic standards, except for the absolute plasma concentrations."( Relative determination of dehydroevodiamine in rat plasma by LC-MS and study on its pharmacokinetics.
Shen, W; Wang, Y; Yan, R; Zhang, X; Zhao, X, 2012
)
0.38

Bioavailability

ExcerptReferenceRelevance
"This study investigates the oral bioavailability and characterizes urine metabolites of dehydroevodiamine (DeHE), one of the bioactive alkaloids isolated from the fruit of Evodia rutaecarpa ."( Pharmacokinetics and urine metabolite identification of dehydroevodiamine in the rat.
Kuo, KL; Li, SH; Lin, LC; Tsai, TH; Wu, YT, 2012
)
0.38
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (47)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (4.26)18.7374
1990's10 (21.28)18.2507
2000's17 (36.17)29.6817
2010's13 (27.66)24.3611
2020's5 (10.64)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (2.08%)5.53%
Reviews1 (2.08%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other46 (95.83%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]